More importantly, the Log-rank analysis confirmed increased SNHG25 expression to be an unfavorable prognostic factor for osteosarcoma patients (HR=2.20, 95% CI: 1.08–4.48, P=0.03). This evidence concerns the gene SNHG25 and osteosarcoma.